188 related articles for article (PubMed ID: 30136662)
1. Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):62-66. PubMed ID: 30136662
[TBL] [Abstract][Full Text] [Related]
2. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
3. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
4. Strengthening regional commitment to ensuring access to medical abortion medicines in WHO's South-East Asia region: report of a participatory assessment and workshop.
Upadhyay MT; Fusire T; Loi UR; Sorhaindo A; Salahuddin M; Hossain MA; Tshomo T; Mulati E; Daisy L; Anggraweni DP; Gultom T; Indrawati F; Jenyfa M; Than MM; Bhattarai B; Moonasinghe L; Mathota C; Jitruknatee A; Cham C; Ganatra B; Raina N
Reprod Health; 2024 May; 20(Suppl 1):191. PubMed ID: 38760864
[TBL] [Abstract][Full Text] [Related]
5. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
6. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
[TBL] [Abstract][Full Text] [Related]
7. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
8. Accelerating access to essential medicines in the WHO South-East Asia Region: opportunities for greater engagement and better evidence.
Khetrapal Singh P; Travis P
WHO South East Asia J Public Health; 2018 Sep; 7(2):59-61. PubMed ID: 30136661
[No Abstract] [Full Text] [Related]
9. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
[TBL] [Abstract][Full Text] [Related]
10. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
11. Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.
Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV
Global Health; 2017 Aug; 13(1):53. PubMed ID: 28764738
[TBL] [Abstract][Full Text] [Related]
12. Country and regional variations in purchase prices for essential cancer medications.
Cuomo RE; Seidman RL; Mackey TK
BMC Cancer; 2017 Aug; 17(1):566. PubMed ID: 28836947
[TBL] [Abstract][Full Text] [Related]
13. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
14. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
[TBL] [Abstract][Full Text] [Related]
15. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
Guan X; Hu H; Man C; Shi L
Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
[TBL] [Abstract][Full Text] [Related]
16. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
18. Access to pain relief and essential opioids in the WHO South-East Asia Region: challenges in implementing drug reforms.
Vallath N; Rajagopal MR; Perera S; Khan F; Paudel BD; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):67-72. PubMed ID: 30136663
[TBL] [Abstract][Full Text] [Related]
19. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean Region.
Salmasi S; Lee KS; Ming LC; Neoh CF; Elrggal ME; Babar ZD; Khan TM; Hadi MA
BMC Cancer; 2017 Dec; 17(1):903. PubMed ID: 29282008
[TBL] [Abstract][Full Text] [Related]
20. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
